Wealthy countries, representing only 13 per cent of the world’s population, have already bought more than 50 per cent of the corona vaccine stock due to global competition to produce the first corona vaccine to its citizens amid the corona epidemic. This is claimed in a report by an organization called Oxfam. According to Oxfam, 5 leading vaccine manufacturers are currently in the final stages of trial. They are able to supply about 5.9 billion doses, which is enough for about 3 billion people. Although about 51 per cent of these doses have already been booked by rich countries like the US, UK, EU, Australia, Hong Kong, Japan, Switzerland and Israel, the remaining 2.6 billion doses were bought by developing countries like India, Bangladesh, China, Brazil, Indonesia and Mexico. Is or promised to buy.